Clinical Trial Imaging Market Growing Demand, Production Scope and Revenue 2026

1. Clinical Trial Imaging Market is anticipated to grow at a CAGR of ~8% by 2026

2. Imaging is a vital component in clinical trials. Medical imaging is an benefit in the drug development process as it can provide efficacy evaluation and safety monitoring data needed in clinical trials for regulatory submission. Moreover, imaging offers insights into the drug mechanism of action (MOA) and drug effects that can assist researchers make scientifically sound decisions. The Clinical Trial Imaging Market is expected to grow at a rate of ~8% by 2026. The rising number of biotechnology & pharmaceutical firms and Contract Research Organizations (CROs), rising R&D spending, the development of innovative imaging modalities such as radiopharmaceuticals, contrast agents, & molecular probes, and increasing research and development investment to develop new drugs and therapies are some of the key features driving the global clinical trial imaging market. Increasing Adoption of Imaging Biomarkers in Clinical Trials Expected to Boost the Clinical Trial Imaging Market Imaging biomarkers are the cornerstone of modern radiology, and imaging endpoints are a critical necessity for patient safety and understanding a drug’s effectiveness. Imaging biomarkers are now more commonly accepted by the FDA as a surrogate endpoint in the traditional and accelerated approval process for new drugs and biologics. Depending upon the usage, imaging biomarkers can be used in various applications such as oncology trials, neurological trials, musculoskeletal trials, and other therapeutic areas.

3. Growing Number of Contract Research Organizations (CROs) Drives the Clinical Trial Imaging Market • Every year, the pharmaceutical industry develops a variety of new drugs that offer valuable medical benefits. Evolving new drugs is a costly and uncertain process, and many potential drugs never make it to the market. Thus, to save costs companies outsource these services to CROs. CROs provide support to pharmaceutical and biotechnology companies in the form of outsourced pharmaceutical research services. • Explore Premium Report on Clinical Trial Imaging Market @ https://meditechinsights.com/clinical-trial-imaging-market/ • Benefits Associated with Clinical Trial Imaging Fuels Its Demand • Imaging techniques bring several advantages to the challenging process of drug development. Some of them include: • Quicker completion of clinical trials • Cost reduction for late-phase clinical trials • Faster approval for orphan disease • Candidate drugs screening efficiency improvement

4. Rise in Usage of Clinical Trial Imaging in Oncology Trials Drives the Clinical Trial Imaging Market Imaging techniques are progressively used in oncological clinical trials to provide evidence for decision-making. With the application of conventional morphological imaging techniques and standardized response criteria based on tumor size measurements, imaging continues to be used to define key study endpoints. In later stages of oncological drug development, imaging forms the basis of robust response and progression criteria to interrogate the drug in a large number of clinical trial subjects. North America Holds the Major Share of the Clinical Trial Imaging Market According to a geological point of view, North America holds a major market share of the clinical trial imaging market followed by Europe. This can be mainly attributed to the increasing number of clinical trials & studies, rising investments by key players for new drug development, and increased funding from the government to support cancer treatment clinical trials in the region. Organic and Inorganic Growth Strategies Adopted by Players to Establish Their Foothold in the Market Players operating in global clinical trial imaging market are adopting organic and inorganic growth strategies such as collaborations, acquisitions, and new product launches to garner market share. 

5. For instance,  • In May 2022, IXICO plc, the neuroimaging Contract Research Organization (CRO) announced that they have entered into a multi-party consortium agreement for the development of improved imaging biomarkers for the early detection and staging of Huntington's disease ('HD') • In January 2022, Clario and XingImaging announced they have expanded their partnership to deliver PET imaging clinical trials for testing novel therapeutics in China • Competitive Landscape Analysis of Clinical Trial Imaging Market • Some of the key players operating in the clinical trial imaging market include Icon plc., BioTelemetry Inc., Biomedical Systems Corporation, Medpace Holdings Inc., and Ixico plc., among others. • For More Comprehensive Insights, Contact Us @ https://meditechinsights.com/contact-us/ • About Medi-Tech Insights • Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services. • Contact: • RutaHalde • Associate, Medi-Tech Insights • +32 498 86 80 79 • info@meditechinsights.com